Appearing as a noteworthy breakthrough in the fight against obesity, this medication is generating considerable attention . It combines effects of two known GLP-1 binding agonists, semaglutide , with an additional glucose-dependent hormonal component. Preliminary clinical results have shown significant fat reduction in patients with excessive weig